![](/img/cover-not-exists.png)
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
Levy, Benjamin P., Giaccone, Giuseppe, Besse, Benjamin, Felip, Enriqueta, Garassino, Marina Chiara, Domine Gomez, Manuel, Garrido, Pilar, Piperdi, Bilal, Ponce-Aix, Santiago, Menezes, Daniel, MacBeth,Volume:
108
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.11.028
Date:
February, 2019
File:
PDF, 1.24 MB
english, 2019